3.67
-0.17 (-4.43%)
-0.17 (-4.43%)
Upgrade to Real-Time
Regular Market
Low
0.52005
High
6.00
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AzurRx BioPharma Inc | AZRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.17 | -4.43% | 3.67 | 14:23:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.84 | 3.57 | 3.845 | 3.84 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.68 | 3.71 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,252 | 768,713 | $ 3.68 | $ 2,831,816 | - | 0.52005 - 6.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:24:27 | 20 | $ 3.68 | USD |
Period:
Draw Mode:
AzurRx BioPharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 34.45M | 9.34M | 9.26M | $ - | $ - | -11.45 | -0.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 200.00k | 1.50% |
AzurRx BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AZRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6403 | 6.00 | 0.54 | 2.58 | 5,598,754 | 3.03 | 473.17% |
| 1 Month | 0.58 | 6.00 | 0.54 | 1.53 | 3,160,165 | 3.09 | 532.76% |
| 3 Months | 0.82 | 6.00 | 0.52005 | 0.8655392 | 4,439,824 | 2.85 | 347.56% |
| 6 Months | 1.50 | 6.00 | 0.52005 | 0.9315259 | 3,400,957 | 2.17 | 144.67% |
| 1 Year | 0.81 | 6.00 | 0.52005 | 1.29 | 3,938,215 | 2.86 | 353.09% |
| 3 Years | 2.61 | 6.00 | 0.370868 | 1.27 | 1,476,271 | 1.06 | 40.61% |
| 5 Years | 5.06 | 6.00 | 0.370868 | 1.31 | 917,617 | -1.39 | -27.47% |
AzurRx BioPharma Description
| AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. Its lead product candidate is MS1819, a yeast-derived recombinant lipase for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP). |
